Ana María Correa-Basurto

N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed <i>in silico</i> with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

Berenice Prestegui-Martel, Jorge Antonio Bermúdez-Lugo, Alma Chávez‐Blanco et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2016 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells

Yudibeth Sixto‐López, Martha Cecilia Rosales‐Hernández, Arturo Contis‐Montes de et al. · International Journal of Molecular Sciences · 2020 · 23 citations · Full text

Medicine, Oncology, Pharmacology +11

<i>N</i>-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells

Arturo Contis‐Montes de, Estefanía Rodarte-Valle, Martha Cecilia Rosales‐Hernández et al. · Oncotarget · 2018 · 19 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +7

Pharmacokinetics and tissue distribution of N-(2-hydroxyphenyl)-2-propylpentanamide in Wistar Rats and its binding properties to human serum albumin

Ana María Correa-Basurto, Aurelio Romero‐Castro, José Correa‐Basurto et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +10